News
KLIFOVET News
StudyBase: the medical and animal health electronic data capture (EDC) system
(23.11.2011)StudyBase, the specifically developped software for data capture of clinical data, has been updated and is now available in various languages including English, German, French, Italian, Portuguese and Hungarian.
The XML based software is validated to FDA 21CFR11 requirements and allows data entry via commercial browser and internet. The complete audit trail guarantees for full transparency of the data. The unique security profile and backup system assures the availability of the data and allows for export to most commercially available other database systems. Interested in this tool for your purposes: get in contact at info@klifovet.com
ISEP 2013: Ludwig Maximilians University and KLIFOVET to host the 12th ISEP 2013 in Munich
(18.07.2011)The International Symposium of Ectoparasites in Pets (ISEP) will take place in Munich, Germany on 7th ot 10th April 2013. The business meeting of the ISEP, held in St. Louis MO, USA accepted the invitation presented by Dr. Klaus Hellmann, CEO of KLIFOVET AG. Prof. Kurt Pfister, head of the Institute of Comparative Tropical Medicine and Parasitology of the veterinary faculty of the Ludwig Maximilians University, welcomed this unique opportunity to host the global community of experts in ectoparasites in pets in Munich; the symposium is planned to cover entomology, vector born diseases, parasiticides and resistance issues. If you are interested, please inquire at isep@klifovet.com.
Collaboration between Argenta Subsidiary AlcheraBio LLC and KLIFOVET AG Provides International Veterinary Contract Research Capability
(03.02.2011)Argenta and AlcheraBio Head of Clinical R&D Dr. Jane Eagleson, and CEO of KLIFOVET AG, Dr. Klaus Hellmann are pleased to announce a collaboration that will provide a unique service to their clients: global clinical studies conducted in both the US and Europe. KLIFOVET AG, established in 1997 and headquartered in Munich, Germany and AlcheraBio, established in 2001 and headquartered in Metuchen, NJ, USA are both leaders in their respective markets for the conduct of clinical efficacy studies and consulting on regulatory affairs of animal health and nutrition products, and have collaborated successfully previously. Both companies will remain independent and no changes to the ownership are planned.
Dr. Hellmann says: “Within the ‘one health – one medicine – one world’ initiative, globalization is even more key for successful animal health companies and their development projects. As innovative CROs we are always seeking for new opportunities to offer our customers the most up-to-date services requested. Global projects have become increasingly more popular in recent years as animal health companies look for options to develop products most efficiently. The collaboration between AlcheraBio and KLIFOVET has already proven very efficient and we will build on this expertise to the best of our clients. Remaining as independent businesses will also assure that both companies will remain fully grounded on their continents and develop to meet the needs of their clients and markets, thus adding value for their clients”.
KLIFOVET AG, awarded the Animal Pharm Award for the Best Supporting Role in 2006, has unique capabilities: their electronic data capture system StudyBase® specifically developed for Animal Health, GMP compliance for animal health clinical supplies, VICH GL9 (GCP) compliance for clinical studies, experienced staff and network being able to handle large multinational, multi-language studies and projects throughout Europe and sharing their know-how at the annual international “Clinical Studies Seminar” in Munich.
“AlcheraBio and Klifovet both have in-house, multidisciplinary clinical study teams that include experienced project development, project management, site training, site monitoring, data management, medical review, and quality assurance personnel,” notes AlcheraBio Chief Operating Officer Dr. Johnny A Jacobsen.
Dr. Jane Eagleson explains that “Klifovet (www.klifovet.com) and AlcheraBio (www.alcherabio.com) are both industry-leading, full-service veterinary clinical contract research organizations and animal health consultancies with exceptional strengths, experience, and scope”. Notes Dr. Eagleson, “Each CRO has a highly trained, permanent staff and a network of established study sites. Globalization in the animal health industry has given AlcheraBio and Klifovet the opportunity to work together, and the two companies’ success has in turn led to this cooperative agreement. Services can be extended by the skills of Argenta, the
KLIFOVET granted GMP for Veterinary Vaccines Clinical Supplies
(31.08.2008)After inspection by the GMP inspectors of the regulatory authorities of Upper Bavaria in July, KLIFOVET is proud to announce that we have received the GMP authorisation of handling, labelling and re-packaging of veterinary vaccines. After receiving a GMP authorisation for veterinary pharmaceutical clinical supplies, this will allow KLIFOVET to support our clients in conducting clinical studies for veterinary medicinal products. And it will reduce the workload of our clients in-house. This is an other example of our strong client orientated focus as service supplier for the development and registration of veterinary medicinal products.
KLIFOVET authorised to place Feed and Feed Additives on the Market
(05.08.2008)After inspection by the regulatory authorities of Upper Bavaria, Feed Department, on 1JUL08, KLIFOVET was granted the permit to place such products on the market including to label feed and feed additives in small quantities. This is a significant improvement in our services for our clients, especially to run efficacy studies in feed (additives) efficiently and timely.
MIC-Isolates
Last Update: 31.01.2012
